Find Out What Trends are Driving the US$2.5 billion Opportunity Projected for Optical Imaging
The global market for Optical Imaging is projected to reach US$2.5 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment.
Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Optical Imaging market. The segments covered in the study include Technique (Optical Coherence Tomography, Hyperspectral Imaging, Near-Infrared Spectroscopy, Photoacoustic Tomography); Therapeutic Type (Oncology, Ophthalmology, Neurology, Cardiology, and Other Therapeutic Types); and End-Use (Hospitals & Clinics, Research Laboratories, Pharma & Biotech).
7 June 5:18 A.M., California/Marketwire/ - According to the new market research report, the global market for Optical Imaging is projected to reach US$2.5 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment. The market will be reset to a new normal which going forwards in a post COVID crisis era will be continuously redefined and redesigned.
Optical imaging, the newest imaging technology capable of revolutionizing healthcare in ways hitherto unimagined, revolves around the use of photons in light to generate images. Growing emphasis on advanced imaging capabilities that provide benefits such as early detection; better diagnosis; detailed visualization of anatomical structures; easy and faster physician understanding of disease complications; better clinical decisions; reduced risk of errors; safer in terms of medical radiation exposure; and better patient outcome, would be instrumental in future growth of optical imaging market. The growing burden of cardiovascular diseases which currently stands at billions of dollars worldwide would be a major revenue draw for Optical Coherence Tomography (OCT). With new cancer diagnosis poised to reach over 20 million per year by 2020, effective optical methods for cancer imaging such as Photoacoustic Imaging will grow in prominence. The emerging field of neuroscience will offer ample market opportunities for the use of Diffuse Optical Tomography (DOT) in anesthesia monitoring and also monitoring psychoactive medications used to treat depression and post-traumatic stress disorder, among others.
Key Competitors Covered in the Report
ASE Optics Europe
Canon U.S.A., Inc.
Carl-Zeiss Meditec AG
Headwall Photonics, Inc.
Heidelberg Engineering GmbH
Koninklijke Philips N.V.
Leica Microsystems GmbH
Optical Imaging Ltd.
Geographies Analyzed in the Report
Europe (France, Germany, Italy, United Kingdom, and Rest of Europe)
Rest of World
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. All analysis and findings published in the report are based on validated engagements from a total executive pool size of 6811. Among this pool, 1092 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 204 unique participations, a total of 92 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world's only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.
Director, Corporate Communications
Global Industry Analysts, Inc.